Systemic sclerosis-A systematic overview: Part 2 - Immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension

Medizin & Biologie

• Pulmonary Arterial Hypertension 100%
• Systemic Scleroderma 96%
• Sclerosis 91%
• Immunosuppression 76%
• Endothelin Receptor Antagonists 63%
• Ulcer 25%
• Raynaud Disease 23%
• Immunosuppressive Agents 23%
• Rheumatic Diseases 20%
• Therapeutics 13%
• Bosentan 13%
• Iloprost 13%
• Heart-Lung Transplantation 13%
• Oral Ulcer 13%
• Familial Primary Pulmonary Hypertension 12%
• Sildenafil Citrate 11%
• Connective Tissue Diseases 11%
• Stem Cell Transplantation 9%
• Connective Tissue 8%
• Prostaglandins 8%
• Steroids 7%
• Calcium 6%
• Kidney 5%
• Pharmaceutical Preparations 3%